About company

LLC “B-PHARM” - Russian manufacturer of medicinal products, that provides population with available, effective, high-quality drugs which improve quality of life

  • Foundation

    Company was founded in 2015

  • Export

    In 2016 export of medicinal and immunobiological drugs was started

  • Manufacture

    Release of the first medicin on a contract manufacturing in 2019

  • Factory

    In 2022 our pharmaceutical factory was launched (Kaluga region, Russia)

2015
Company launch, wholesale pharmaceutical activity in Russian Federation
2016
Company’s export activities start
2017
B-PHARM own medicines registration start
2018
First MA certificate for a medicinal product
2019 july
Construction of our own factory started
2019 september
Production of the first series of patented drugs at contract manufacturing facility
2020
Start of sales of own medicinal products
2021 december
Obtaining a license to manufacture pharmaceuticals (own factory)
2022 february
Obtaining GMP certificate (EAEU/RU) for B-PHARM production site
2022 march
Launch of the physicochemical laboratory at the factory
2022 september
Launch of the 1st stage of the factory for the production of injectable drugs
  • 1

    Registered medicines in the portfolio (Russian Federation)

  • 1

    Of which have already been released in Russian Federation market

  • 1

    Countries, where a registration of medicines and dietary supplements is currently being carried out

  • > 1

    Medicines at different stages of R&D

Registration of medicines

Production facilities are GMP certified

Full control of the production cycle - from an API to a finished dosage form

Modern equipment and quality control methods

Highly qualified staff

90% automation

Mission

Our mission - to preserve health and improve quality of life by developing and producing effective, high-quality and affordable medicines

Goals

Main company goal - registration and production of effective and affordable medicines, introduce drugs to Russian market and markets of other countries, for the development of a system of medicine provision of citizens, by expanding the company's product range with demanded medicines

Advances

  • We have registered more than 39 drugs in the first 5 years in Russian Federation and other countries
  • We built and launched our own pharmaceutical factory for the production of injectable drugs in 3 years

Principles

  • Honesty
  • High quality
  • Social responsibility
  • Dynamic development
Keeping the main thing!